Scott Hall’s scholarly research over the past 25 years has focused on understanding autistic symptoms in children with neurogenetic disorders such as Fragile X syndrome, to determine how environmental and biological factors affect the development of these behaviors, toward the goal of creating patient-specific treatments. He is extensively trained in behavioral assessment and interventions, and provides clinical evaluations and consultation as a doctoral-level Board Certified Behavior Analyst (BCBA-D). He is particularly interested in developing targeted treatments that can be delivered via telehealth.

Dr. Hall received his bachelor’s from Goldsmiths’ College, University of London, England; and his doctorate from the Institute of Psychiatry, King’s College, University of London, England.